The PLASMACELL Xi brand, founded in 2014 (United States), from 281 sister brands and 620 competing brands. PLASMACELL Xi is owned by FRESENIUS, listed on the stock exchange of Francfort The International Securities Identification Number (ISIN) of FRESENIUS is DE0005785604. PLASMACELL Xi belongs to the Healthcare Providers & Services business sector.

Share price and profitability of the share FRESENIUS (PLASMACELL Xi)

Buy FRESENIUS share with
(0% commission and fractional shares)
Your capital is subject to risk. Other fees apply. For more information, visit etoro.com/trading/fees.

Investment simulator :

Amount invested EUR 27.05

Portfolio valuation
FRESENIUS (PLASMACELL Xi) over 5 years* EUR 14.31

Stock market history FRESENIUS (PLASMACELL Xi)

*non inclusive of dividends, non inclusive of market orders
past performances do not prejudice future performances

Other brands
FRESENIUS

Fresenius
Fresenius
Fresenius Kabi
Fresenius Kabi
See more brands of FRESENIUS

Rival brands
PLASMACELL Xi

Clariane
Clariane
Gambro
Gambro
MedSleuth
MedSleuth
CenterPointe
CenterPointe
Alles Lægehus
Alles Lægehus
Ita mental health
Ita mental health
OTHER RIVAL BRANDS

Top Popularity Web

See the full ranking